Strengths of the French end-of-life Law as Well as its Shortcomings in Handling Intractable Disputes Between Physicians and Families.


Journal

The New bioethics : a multidisciplinary journal of biotechnology and the body
ISSN: 2050-2885
Titre abrégé: New Bioeth
Pays: England
ID NLM: 101627814

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 18 2 2020
medline: 11 11 2020
entrez: 18 2 2020
Statut: ppublish

Résumé

French end-of-life law aims at protecting patients from unreasonable treatments, but has been used to force caregivers to prolong treatments deemed unreasonable. We describe six cases (five intensive care unit patients including two children) where families disagreed with a decision to withdraw treatments and sued medical teams. An emergent inquiry was instigated by the families. In two cases, the court rejected the families' inquiries. In two cases, the families appealed the decision, and in both the first jurisdiction decision was confirmed, compelling caregivers to pursue treatments, even though they deemed them unreasonable. We discuss how this law may be perverted. Legal procedures may result in the units' disorganisation and give rise to caregivers' stress. Families' requests may be subtended by religious beliefs. French end-of-life law has benefits in theoretically constraining physicians to withhold or withdraw disproportionate therapies. These cases underline some caveats and the perverse effects of its literal reading.

Identifiants

pubmed: 32065064
doi: 10.1080/20502877.2020.1720421
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-74

Auteurs

Jonathan Messika (J)

Université de Paris, Infection, Antimicrobials, Modelling, Evolution, IAME, UMR 1137, INSERM, Paris, France.
Service de Réanimation Médico-Chirurgicale, AP-HP, Hôpital Louis Mourier, Colombes, France.

Noël Boussard (N)

CHRU Nancy-Brabois, Hôpital d'Enfants, Réanimation Pédiatrique Spécialisée, Vandoeuvre-Les-Nancy, France.

Claude Guérin (C)

Hospices civils de Lyon, Médecine intensive-Réanimation, Hôpital de la Croix-Rousse, Lyon, France.
Université de Lyon, Lyon, France.
INSERM 955, Créteil, France.

Fabrice Michel (F)

AP-HM Pediatric Anesthesia and Intensive Care Timone Hospital, Marseille, France.
Aix-Marseille Univ. CNRS, EFS, Marseille, France.

Saad Nseir (S)

CHU Lille, Critical Care Center, Lille, France.
School of Medicine, University of Lille, Lille, France.

Hodane Yonis (H)

Hospices civils de Lyon, Médecine intensive-Réanimation, Hôpital de la Croix-Rousse, Lyon, France.

Claire-Marie Barbier (CM)

CHRU Nancy-Brabois, Hôpital d'Enfants, Réanimation Pédiatrique Spécialisée, Vandoeuvre-Les-Nancy, France.

Anahita Rouzé (A)

CHU Lille, Critical Care Center, Lille, France.

Virginie Fouilloux (V)

AP-HM Pediatric Cardiac Surgery, Timone Hospital, Marseille, France.

Stephane Gaudry (S)

AP-HP Hôpital Avicenne, Service de Réanimation Médico-Chirurgicale, Bobigny, France.
French National Institute of Health and Medical Research (INSERM), UMR_S1155, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine, Sorbonne Université, Hôpital Tenon, Paris, France.

Jean-Damien Ricard (JD)

Université de Paris, Infection, Antimicrobials, Modelling, Evolution, IAME, UMR 1137, INSERM, Paris, France.
Service de Réanimation Médico-Chirurgicale, AP-HP, Hôpital Louis Mourier, Colombes, France.

Henry Silverman (H)

University of Maryland School of Medicine, Baltimore, MD, USA.

Didier Dreyfuss (D)

Service de Réanimation Médico-Chirurgicale, AP-HP, Hôpital Louis Mourier, Colombes, France.
French National Institute of Health and Medical Research (INSERM), UMR_S1155, Common and Rare Kidney Diseases: from Molecular Events to Precision Medicine, Sorbonne Université, Hôpital Tenon, Paris, France.
Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH